The clinical relevance of Asb2 has been evident in the Gene Expression Omnibus (GEO) database, but contrary to our expectation, Asb2 expression was decreased in the vastus lateralis skeletal muscles of patients with myotonic dystrophy type 2 (GEO accession GDS5276). The gene discussed is ASB2; the disease is myotonic dystrophy type 2.